日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Potent, Selective, Water Soluble, Brain-Permeable EP2 Receptor Antagonist for Use in Central Nervous System Disease Models

强效、选择性、水溶性、可渗透脑的 EP2 受体拮抗剂,可用于中枢神经系统疾病模型

Radhika Amaradhi, Avijit Banik, Shabber Mohammed, Vidyavathi Patro, Asheebo Rojas, Wenyi Wang, Damoder Reddy Motati, Ray Dingledine, Thota Ganesh

Inhibition of the prostaglandin EP2 receptor prevents long-term cognitive impairment in a model of systemic inflammation

抑制前列腺素 EP2 受体可预防全身炎症模型中的长期认知障碍

Chunxiang Jiang, Aysegul Caskurlu, Thota Ganesh, Ray Dingledine

Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties

具有抗炎特性的外周限制性、高效、选择性、水溶性 EP2 拮抗剂

Thota Ganesh, Avijit Banik, Ray Dingledine, Wenyi Wang, Radhika Amaradhi

Lead optimization studies of cinnamic amide EP2 antagonists

肉桂酰胺EP2拮抗剂的先导化合物优化研究

Thota Ganesh, Jianxiong Jiang, Myung-Soon Yang, Ray Dingledine

EP2 receptor signaling pathways regulate classical activation of microglia

EP2 受体信号通路调节小胶质细胞的经典活化

Yi Quan, Jianxiong Jiang, Ray Dingledine

Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation

前列腺素受体EP2在癌细胞增殖、侵袭和炎症调控中的作用

Jianxiong Jiang, Ray Dingledine

Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F

通过小分子抑制翻译起始复合物 eIF4F 来逆转化学耐药性

Regina Cencic, David R Hall, Francis Robert, Yuhong Du, Jaeki Min, Lian Li, Min Qui, Iestyn Lewis, Serdar Kurtkaya, Ray Dingledine, Haian Fu, Dima Kozakov, Sandor Vajda, Jerry Pelletier